On 3 July 2025, WHO/Europe proposed that all alcoholic beverages sold in the EU carry clear warnings about cancer risks. The recommendation is based on consolidated data linking alcohol consumption to several cancers, including liver, breast, and colorectal cancers.
The initiative aims to increase consumer awareness. Some member states, such as Ireland, are already implementing similar regulations. WHO encourages harmonized rules at the European level by incorporating warnings directly into product labels.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959